$WST
WEST PHARMACEUTICAL SERVICES INC

2017 Q2 Form 10-Q Financial Statement

#000010577017000042 Filed on August 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $397.6M $388.0M
YoY Change 2.47% 7.87%
Cost Of Revenue $272.6M $254.7M
YoY Change 7.03% 5.47%
Gross Profit $125.0M $133.3M
YoY Change -6.23% 12.77%
Gross Profit Margin 31.44% 34.36%
Selling, General & Admin $61.30M $62.50M
YoY Change -1.92% 2.8%
% of Gross Profit 49.04% 46.89%
Research & Development $10.00M $8.800M
YoY Change 13.64% 8.64%
% of Gross Profit 8.0% 6.6%
Depreciation & Amortization $23.50M $22.70M
YoY Change 3.52% 2.25%
% of Gross Profit 18.8% 17.03%
Operating Expenses $71.30M $71.30M
YoY Change 0.0% 3.48%
Operating Profit $42.00M $61.20M
YoY Change -31.37% 56.52%
Interest Expense $2.200M $2.000M
YoY Change 10.0% -41.18%
% of Operating Profit 5.24% 3.27%
Other Income/Expense, Net $600.0K
YoY Change
Pretax Income $40.70M $59.50M
YoY Change -31.6% 64.82%
Income Tax $2.900M $17.00M
% Of Pretax Income 7.13% 28.57%
Net Earnings $38.80M $44.70M
YoY Change -13.2% 60.79%
Net Earnings / Revenue 9.76% 11.52%
Basic Earnings Per Share $0.53 $0.61
Diluted Earnings Per Share $0.51 $0.60
COMMON SHARES
Basic Shares Outstanding 73.90M shares 73.30M shares
Diluted Shares Outstanding 75.80M shares 74.80M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $226.6M $202.7M
YoY Change 11.79% -19.56%
Cash & Equivalents $226.6M $202.7M
Short-Term Investments
Other Short-Term Assets $37.50M $39.80M
YoY Change -5.78% 18.1%
Inventory $211.3M $197.7M
Prepaid Expenses
Receivables $242.4M $219.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $717.8M $659.2M
YoY Change 8.89% -3.04%
LONG-TERM ASSETS
Property, Plant & Equipment $811.8M $741.2M
YoY Change 9.53% 8.14%
Goodwill $105.8M $104.9M
YoY Change 0.86% -0.38%
Intangibles $22.90M $24.90M
YoY Change -8.03% -36.8%
Long-Term Investments $70.20M $64.30M
YoY Change 9.18% 7.53%
Other Assets $16.00M $22.50M
YoY Change -28.89% -17.88%
Total Long-Term Assets $1.125B $1.046B
YoY Change 7.58% 6.31%
TOTAL ASSETS
Total Short-Term Assets $717.8M $659.2M
Total Long-Term Assets $1.125B $1.046B
Total Assets $1.843B $1.705B
YoY Change 8.09% 2.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.9M $107.3M
YoY Change 21.99% 17.4%
Accrued Expenses $50.40M $60.70M
YoY Change -16.97% 10.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $33.80M $2.500M
YoY Change 1252.0% -97.37%
Total Short-Term Liabilities $289.0M $239.4M
YoY Change 20.72% -23.69%
LONG-TERM LIABILITIES
Long-Term Debt $195.7M $228.9M
YoY Change -14.5% -1.21%
Other Long-Term Liabilities $46.60M $51.70M
YoY Change -9.86% 3.82%
Total Long-Term Liabilities $242.3M $280.6M
YoY Change -13.65% -0.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $289.0M $239.4M
Total Long-Term Liabilities $242.3M $280.6M
Total Liabilities $600.6M $595.7M
YoY Change 0.82% -11.66%
SHAREHOLDERS EQUITY
Retained Earnings $1.148B $1.014B
YoY Change 13.24% 7.05%
Common Stock $18.70M $18.40M
YoY Change 1.63% 2.22%
Preferred Stock
YoY Change
Treasury Stock (at cost) $64.80M $13.10M
YoY Change 394.66% 227.5%
Treasury Stock Shares 800.0K shares 200.0K shares
Shareholders Equity $1.242B $1.109B
YoY Change
Total Liabilities & Shareholders Equity $1.843B $1.705B
YoY Change 8.09% 2.49%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $38.80M $44.70M
YoY Change -13.2% 60.79%
Depreciation, Depletion And Amortization $23.50M $22.70M
YoY Change 3.52% 2.25%
Cash From Operating Activities $85.30M $76.20M
YoY Change 11.94% -1.68%
INVESTING ACTIVITIES
Capital Expenditures $29.50M $35.00M
YoY Change -15.71% 31.09%
Acquisitions
YoY Change
Other Investing Activities -$6.000M -$7.600M
YoY Change -21.05% -733.33%
Cash From Investing Activities -$35.50M -$42.60M
YoY Change -16.67% 67.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.300M -7.400M
YoY Change -131.08% -30.84%
NET CHANGE
Cash From Operating Activities 85.30M 76.20M
Cash From Investing Activities -35.50M -42.60M
Cash From Financing Activities 2.300M -7.400M
Net Change In Cash 52.10M 26.20M
YoY Change 98.85% -36.56%
FREE CASH FLOW
Cash From Operating Activities $85.30M $76.20M
Capital Expenditures $29.50M $35.00M
Free Cash Flow $55.80M $41.20M
YoY Change 35.44% -18.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000105770
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74002454 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES INC
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122000000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
6000000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
130900000 USD
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2016Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
15000000 USD
CY2017Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
200500000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
242400000 USD
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4500000 USD
CY2017Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2400000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
776400000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
834900000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-186800000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-151800000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
260400000 USD
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
292300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1400000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3800000 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-4700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7100000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9500000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5500000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000 USD
CY2016Q4 us-gaap Assets
Assets
1716700000 USD
CY2017Q2 us-gaap Assets
Assets
1843000000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
641900000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
717800000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
7600000 USD
CY2017Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
8100000 USD
CY2016Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1700000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1900000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
400000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
700000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8000000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8500000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
274600000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202700000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203000000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226600000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-71900000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23600000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73700000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74800000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73100000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74000000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
18400000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
18700000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
42400000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
79200000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
66000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
134700000 USD
CY2016Q4 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2017Q2 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
254700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
493500000 USD
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
272600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
526200000 USD
CY2017Q2 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-4100000 USD
CY2016Q4 us-gaap Debt Current
DebtCurrent
2400000 USD
CY2017Q2 us-gaap Debt Current
DebtCurrent
33800000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
228600000 USD
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
229500000 USD
CY2016Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2017Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-11100000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-11100000 USD
CY2016Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8400000 USD
CY2017Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9600000 USD
CY2016Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
7400000 USD
CY2017Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
8000000 USD
CY2013Q2 us-gaap Deferred Revenue
DeferredRevenue
20000000 USD
CY2017Q2 us-gaap Deferred Revenue
DeferredRevenue
13600000 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1500000 USD
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
12100000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
66200000 USD
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
85100000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9200000 USD
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9200000 USD
CY2016Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-800000 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-1600000 USD
CY2017Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-800000 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-1300000 USD
CY2016Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-300000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-700000 USD
CY2017Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-600000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-1100000 USD
CY2016Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3200000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
6300000 USD
CY2017Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3300000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
6700000 USD
CY2016Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2700000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5400000 USD
CY2017Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2500000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5100000 USD
CY2016Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2800000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
5600000 USD
CY2017Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2000000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3900000 USD
CY2016Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2800000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
5600000 USD
CY2017Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2600000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
5300000 USD
us-gaap Depreciation
Depreciation
43700000 USD
us-gaap Depreciation
Depreciation
45400000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19200000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.90
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2600000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7300000 USD
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.274
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.071
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51600000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48100000 USD
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
69300000 USD
CY2017Q2 us-gaap Equity Method Investments
EquityMethodInvestments
70200000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
13100000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
700000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
200000 USD
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6000000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8000000 USD
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8500000 USD
CY2016Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
200000 USD
CY2017Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
100000 USD
CY2016Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1600000 USD
CY2017Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
4900000 USD
CY2016Q2 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 USD
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
2700000 USD
CY2017Q2 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 USD
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 USD
CY2016Q4 us-gaap Goodwill
Goodwill
103000000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
105800000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
133300000 USD
us-gaap Gross Profit
GrossProfit
256600000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
125000000 USD
us-gaap Gross Profit
GrossProfit
259100000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
87300000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
100200000 USD
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2200000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3500000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4600000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23900000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000 USD
us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
3500000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-3300000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3600000 USD
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2100000 shares
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23300000 USD
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22900000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
2000000 USD
us-gaap Interest Expense
InterestExpense
4500000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
2300000 USD
us-gaap Interest Expense
InterestExpense
4400000 USD
CY2016Q4 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
1000000 USD
CY2017Q2 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
400000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
92400000 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
92500000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
199300000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
211300000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
78000000 USD
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
85500000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28900000 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
33300000 USD
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
300000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
600000 USD
CY2017Q2 us-gaap Investment Income Net
InvestmentIncomeNet
300000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
600000 USD
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
82700000 USD
CY2017Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
83600000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
599200000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
600600000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1716700000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1843000000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
241000000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
289000000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
19000000 USD
CY2017Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
23400000 USD
CY2016Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
228300000 USD
CY2017Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
199300000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
226200000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
195700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-72500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19500000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
79200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
106000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
91200000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42700000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
104000000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39100000 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
37500000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21300000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5400000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5100000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-3000000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-2900000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
34000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1400000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
700000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-2900000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1200000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
700000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
500000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-1100000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-300000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4900000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
36300000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
42200000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12300000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1200000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1600000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
800000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
900000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
400000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
600000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-300000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-400000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58300000 USD
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
71500000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47200000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
60500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
57000000 USD
CY2016Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1400000 USD
CY2017Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-600000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1600000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1200000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2800000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17200000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26900000 USD
CY2016 us-gaap Payments For Restructuring
PaymentsForRestructuring
3000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1700000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17500000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3700000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3800000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
8400000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000000 USD
CY2016Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2200000 USD
CY2017Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2300000 USD
CY2016Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
75600000 USD
CY2017Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
60100000 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1700000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2200000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-200000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29500000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
44700000 USD
us-gaap Profit Loss
ProfitLoss
66900000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
38800000 USD
us-gaap Profit Loss
ProfitLoss
99700000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1554700000 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1646700000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
778300000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
811800000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
68600000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1200000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8800000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18200000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20300000 USD
CY2016Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
-1500000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
21400000 USD
CY2016 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
26400000 USD
CY2017Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
CY2016Q2 us-gaap Restructuring Charges
RestructuringCharges
-1500000 USD
us-gaap Restructuring Charges
RestructuringCharges
21400000 USD
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
5900000 USD
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
4200000 USD
CY2016 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
17500000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1071600000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1148000000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
388000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
750100000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
397600000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
785300000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120600000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122200000 USD
CY2016Q2 us-gaap Severance Costs1
SeveranceCosts1
-1500000 USD
us-gaap Severance Costs1
SeveranceCosts1
6400000 USD
CY2017Q2 us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.199
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0205
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4617729 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
437452 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
83.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32400000 USD
CY2016Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
800000 shares
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1117500000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1242400000 USD
CY2017Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0.00
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
82.84
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
600000 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
CY2017Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
325000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
46100000 USD
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
64800000 USD
CY2017Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26900000 USD
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
900000 USD
CY2017Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
800000 USD
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74500000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75700000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72900000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73600000 shares
wst Asset Impairment Charges Patentand Equipment
AssetImpairmentChargesPatentandEquipment
5000000 USD
wst Asset Impairment Charges Trademark
AssetImpairmentChargesTrademark
10000000 USD
CY2016Q2 wst Development Income
DevelopmentIncome
400000 USD
wst Development Income
DevelopmentIncome
800000 USD
CY2017Q2 wst Development Income
DevelopmentIncome
400000 USD
wst Development Income
DevelopmentIncome
800000 USD
CY2016Q2 wst Other Income Expense
OtherIncomeExpense
-800000 USD
wst Other Income Expense
OtherIncomeExpense
-26600000 USD
CY2017Q2 wst Other Income Expense
OtherIncomeExpense
-11700000 USD
wst Other Income Expense
OtherIncomeExpense
-12600000 USD

Files In Submission

Name View Source Status
0000105770-17-000042-index-headers.html Edgar Link pending
0000105770-17-000042-index.html Edgar Link pending
0000105770-17-000042.txt Edgar Link pending
0000105770-17-000042-xbrl.zip Edgar Link pending
ex311q22017.htm Edgar Link pending
ex312q22017.htm Edgar Link pending
ex321q22017.htm Edgar Link pending
ex322q22017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wst-20170630.xml Edgar Link completed
wst-20170630.xsd Edgar Link pending
wst-20170630_cal.xml Edgar Link unprocessable
wst-20170630_def.xml Edgar Link unprocessable
wst-20170630_lab.xml Edgar Link unprocessable
wst-20170630_pre.xml Edgar Link unprocessable
wst10q63017.htm Edgar Link pending